Home  >  News
Eppen_Ultracentrifuge_May2026
you can get e-magazine links on WhatsApp. Click here
News
  BeOne Medicines’ sonrotoclax receives US FDA approval as first and only BCL2 inhibitor for R/R mantle cell lymphoma,   May 16, 2026
  US FDA approves AstraZeneca’s Fasenra for hypereosinophilic syndrome,   May 16, 2026
  79th WHA to take place on 18-23 May 2026; would advance progress towards achieving indivisible goals of gender equality and #HealthForAll?,   May 15, 2026
  Chugai files regulatory application with Japan MHLW for humanized anti-CD20 monoclonal antibody Gazyva for an additional indication of idiopathic nephrotic syndrome,   May 15, 2026
  Infex Therapeutics secures £4.3 million funding to advance anti-infective pipeline targeting drug-resistant infections,   May 14, 2026
  Boehringer Ingelheim licenses preclinical antibody programme from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases,   May 14, 2026
  Pfizer’s Hympavzi receives European approval to treat adults and adolescents with haemophilia A or B with inhibitors,   May 14, 2026
  European Medicines Agency welcomes political agreement on Critical Medicines Act,   May 13, 2026
  US FDA advances drug repurposing to address unmet medical needs,   May 13, 2026
  US FDA accepts Transpire Bio’s ANDA filing for generic high-strength Trelegy Ellipta,   May 12, 2026
  Partner Therapeutics’ Bizengri gets US FDA approval for NRG1 fusion-positive cholangiocarcinoma following receipt of FDA commissioner’s National Priority Voucher,   May 12, 2026
  Daiichi Sankyo unveils new five-year business plan focused on oncology leadership and innovation,   May 12, 2026
  US FDA grants approval to Partner Therapeutics’ Bizengri to treat NRG1 fusion-positive cholangiocarcinoma under the National Priority Voucher Pilot Programme,   May 11, 2026
  European Commission approves Bristol Myers Squibb’s Sotyktu for the treatment of active psoriatic arthritis in adults,   May 11, 2026
  US FDA issues guidance to improve collection of pregnancy safety data for drugs and biologics,   May 11, 2026
  Rznomics’ RZ-001 receives US FDA Regenerative Medicine Advanced Therapy Designation for the treatment of hepatocellular carcinoma,   May 11, 2026
  US FDA clears Harbour BioMed’s IND application for HBM7004 to treat advanced solid tumours,   May 11, 2026
  Indian pharma views US FDA’s global one-day inspection drive to strengthen its production quality capability,   May 11, 2026
  Plus Therapeutics’ wholly owned subsidiary, CNSide Diagnostics receives Medicare enrollment approval,   May 09, 2026
  Altasciences and Certara ink strategic partnership to accelerate early drug development,   May 09, 2026

 Back
 
Propak_Asia_2026
APME-2026.gif
echemi_logo26
echemi_logo26
API_China2026
CP_CPHI_Korea2026
IWE_CP_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram